Should we continue to test soluble thrombomodulin, or other systemic anticoagulants, as a life-saving therapy for sepsis-induced coagulopathy?

Anaesth Crit Care Pain Med. 2019 Oct;38(5):419-421. doi: 10.1016/j.accpm.2019.09.003.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anticoagulants
  • Blood Coagulation Disorders*
  • Disseminated Intravascular Coagulation*
  • Humans
  • Sepsis*
  • Thrombomodulin

Substances

  • Anticoagulants
  • Thrombomodulin